These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25217422)

  • 21. Survival outcomes of locally advanced prostate cancer in patients aged < 50 years after local therapy in the contemporary US population.
    Sheng W; Zhang H; Lu Y
    Int Urol Nephrol; 2018 Aug; 50(8):1435-1444. PubMed ID: 29982959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients.
    Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Fossati N; Gandaglia G; Gallina A; Abdollah F; Shariat SF; Montorsi F; Saad F; Tilki D; Briganti A; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):381-388. PubMed ID: 29366856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of radical prostatectomy for the treatment of metastatic prostate cancer: a systematic review and meta-analysis.
    Wang Y; Qin Z; Wang Y; Chen C; Wang Y; Meng X; Song N
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29263146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.
    Abdollah F; Sun M; Schmitges J; Tian Z; Jeldres C; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Eur Urol; 2011 Nov; 60(5):920-30. PubMed ID: 21741762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients.
    Wenzel M; Collà Ruvolo C; Würnschimmel C; Nocera L; Tian Z; Saad F; Briganti A; Tilki D; Graefen M; Becker A; Roos F; Mandel P; Chun FKH; Karakiewicz PI
    Prostate; 2022 Jan; 82(1):78-85. PubMed ID: 34633102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations.
    Leyh-Bannurah SR; Karakiewicz PI; Pompe RS; Preisser F; Zaffuto E; Dell'Oglio P; Briganti A; Nafez O; Fisch M; Steuber T; Graefen M; Budäus L
    World J Urol; 2019 Mar; 37(3):469-479. PubMed ID: 29992380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study.
    Pompe RS; Smith A; Bandini M; Marchioni M; Martel T; Preisser F; Leyh-Bannurah SR; Schiffmann J; Saad F; Huland H; Graefen M; Shariat SF; Tilki D; Karakiewicz PI
    Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):71-77. PubMed ID: 29339806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study.
    Bandini M; Pompe RS; Marchioni M; Zaffuto E; Gandaglia G; Fossati N; Cindolo L; Montorsi F; Briganti A; Saad F; Karakiewicz PI
    Int Urol Nephrol; 2018 Jan; 50(1):71-78. PubMed ID: 29129028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
    J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical Prostatectomy.
    Moschini M; Briganti A; Murphy CR; Bianchi M; Gandaglia G; Montorsi F; Quevedo JF; Carlson R; Kwon E; Karnes RJ
    Eur Urol; 2016 Feb; 69(2):193-6. PubMed ID: 26264160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger Than 60 Years.
    Huang H; Muscatelli S; Naslund M; Badiyan SN; Kaiser A; Siddiqui MM
    J Urol; 2019 Jan; 201(1):120-128. PubMed ID: 30059685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study.
    Moschini M; Fossati N; Sood A; Lee JK; Sammon J; Sun M; Pucheril D; Dalela D; Montorsi F; Karnes RJ; Briganti A; Trinh QD; Menon M; Abdollah F
    Eur Urol Focus; 2018 Jan; 4(1):68-74. PubMed ID: 28753764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of age at diagnosis on prostate cancer mortality: a grade-for-grade and stage-for-stage analysis.
    Gandaglia G; Karakiewicz PI; Abdollah F; Becker A; Roghmann F; Sammon JD; Kim SP; Perrotte P; Briganti A; Montorsi F; Trinh QD; Sun M
    Eur J Surg Oncol; 2014 Dec; 40(12):1706-15. PubMed ID: 24915856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of initial local therapy on survival in men later receiving chemotherapy for prostate cancer: a population-based, propensity-weighted multivariable analysis.
    Zabell JR; Adejoro O; Jarosek SL; Elliott SP; Konety BR
    World J Urol; 2016 Oct; 34(10):1397-403. PubMed ID: 26914817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study.
    Abdollah F; Schmitges J; Sun M; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Prostate; 2011 Oct; 71(14):1587-94. PubMed ID: 21480307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives.
    Bayne CE; Williams SB; Cooperberg MR; Gleave ME; Graefen M; Montorsi F; Novara G; Smaldone MC; Sooriakumaran P; Wiklund PN; Chapin BF
    Eur Urol; 2016 May; 69(5):775-87. PubMed ID: 26003223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer.
    Dell'Oglio P; Bishr M; Boehm K; Trudeau V; Larcher A; Tian Z; Sosa J; Moschini M; Saad F; Capitanio U; Briganti A; Graefen M; Montorsi F; Karakiewicz PI
    Eur Urol Focus; 2018 Dec; 4(6):834-841. PubMed ID: 28753853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different therapeutic regimens in the treatment of metastatic prostate cancer by performing a Bayesian network meta-analysis.
    Zhang Q; Cheng H; Wang Y; Tian Y; Xia J; Wang Y; Zhou X; Meng X; Wang Y; Gu M; Song N
    Int J Surg; 2019 Jun; 66():28-36. PubMed ID: 31002882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models.
    Boehm K; Larcher A; Beyer B; Tian Z; Tilki D; Steuber T; Karakiewicz PI; Heinzer H; Graefen M; Budäus L
    Eur Urol; 2016 Jun; 69(6):1038-43. PubMed ID: 26272236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.